Serine proteases and brain damage - Is there a link?

Trends in Neurosciences

Volumn 23, Issue 9, 2000, Pages 399-407

  Gingrich, Melissa B ^a   Traynelis, Stephen F ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CARBON DIOXIDE; OXYGEN; PLASMIN; SERINE PROTEINASE; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR;

BLOOD BRAIN BARRIER; BRAIN INJURY; CEREBROVASCULAR ACCIDENT; DIFFUSION; EPILEPTIC STATE; EXTRACELLULAR SPACE; GLIA; HEAD INJURY; NERVE CELL NECROSIS; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW; STROKE;

EID: 0034284153     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(00)01617-9     Document Type: Note

References (85)

1. Vu, T-K.H. et al. (1991) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64, 1057-1068
2. Nystedt, S. et al. (1994) Molecular cloning of a potential novel proteinase activated receptor. Proc. Natl. Acad. Sci U. S. A. 91, 9208-9212
3. Ishihara, H. et al. (1997) Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386, 502-506
4. Kahn, M.L. et al. (1998) A dual thrombin receptor system for platelet activation. Nature 394, 690-694
5. Xu, W-F. et al. (1998) Cloning and characterization of human protease-activated receptor 4. Proc. Natl. Acad. Sci U. S. A. 95, 6642-6646
6. Kahn, M.L. et al. (1998) Gene and locus structure and chromosomal localization of the protease-activated receptor gene family. J. Biol. Chem. 273, 23290-23296
7. Vu, T-K.H. et al. (1991) Domains specifying thrombin-receptor interaction. Nature 353, 674-677
8. Grand, R.J.A. et al. (1996) Cellular consequences of thrombin-receptor activation. Biochem. J. 313, 353-368
9. Dery, O. et al. (1998) Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am. J. Physiol. 274, C1429-C1452
10. Chen, J. et al. (1994) Thrombin receptor activation. J. Biol. Chem. 269, 16041-16045
11. Kuliopulos, A. et al. (1999) Plasmin desensitization of the PARI thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy. Biochemistry 38, 4572-4585
12. Hollenberg, M.D. et al. (1997) Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides. Can. J. Physiol. Pharmacol. 75, 832-841
13. Yang, Y. et al. (1997) Thrombin receptor on rat primary hippocampal neurons: coupled calcium and cAMP responses. Brain Res. 761, 11-18
14. Gingrich, M.B. et al. (2000). Potentiation of NMDA receptor function by the serine protease thrombin. J. Neurosci. 20, 4582-4595
15. Snider, R.M. et al. (1986) Activation of cyclic nucleotide formation in neuroblastoma cells. Semin. Throm. Hemostasis 12, 253-262
16. Grabham, P. and Cunningham, D.D. (1995) Thrombin receptor activation stimulates astrocyte proliferation and reversal of stellation by distinct pathways: involvement of tyrosine phosphorylation. J. Neurochem. 64, 583-591
17. Donovan, F.M. et al. (1997) Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J. Neurosci. 17, 5316-5326
18. Brass, L.F. et al. (1994) Changes in the structure and function of the human thrombin receptor during receptor activation, internalization, and recycling. J. Biol. Chem 269, 2943-2952
19. Ishii, K. et al. (1994) Inhibition of thrombin receptor signaling by a G-protein coupled receptor kinase. J. Biol. Chem. 269, 1125-1130
20. Turgeon, V.L. and Houenou, L.J. (1997) The role of thrombin-like proteases in the development, plasticity, and pathology of the nervous system. Brain Res. Rev. 25, 85-95
21. Weinstein, J.R. et al. (1998) Injury-related factors and conditions down-regulate the thrombin receptor (PAR-1) in a human neuronal cell line. J. Neurochem. 71, 1034-1050
22. Hammes, S.R. and Coughlin, S.R. (1999) Protease-activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: evidence for a novel mechanism for preventing or terminating signaling by PAR1's tethered ligand. Biochemistry 38, 2486-2493
23. Weinstein, J.R. et al. (1995) Cellular localization of thrombin receptor mRNA in rat brain: expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA. J. Neurosci. 15, 2906-2919
24. Niclou, S.P. et al. (1998) Changes in the expression of protease-activated receptor 1 and protease nexin-1 mRNA during rat nervous system development and after nerve lesion. Eur. J. Neurosci. 10, 1590-1607
25. Dihanich, M. et al. (1991) Prothrombin mRNA is expressed by cells of the nervous system. Neuron 6, 575-581
26. Smith-Swintosky, V.L. et al. (1997) Protease-activated receptor-2 (PAR-2) is present in the rat hippocampus and is associated with neurodegeneration. J. Neurochem. 69, 1890-1896
27. Mentz, S.M. et al. (1999) Mechanism of thrombin clearance by human astrocytoma cells. J. Neurochem. 72, 980-987
28. Choi, B.H. et al. (1990) Protease nexin-1: localization in the human brain suggests a protective role against extravasated serine proteases. Am. J. Pathol. 137, 741-747
29. Festoff, B.W. et al. (1996) Prevention of activity-dependent neuronal death: vasoactive intestinal polypeptide stimulates astrocytes to secrete the thrombin-inhibiting neurotrophic serpin, protease nexin-1. J. Neurobiol. 30, 255-266.
30. 2+ homeostasis and sensitivity to glucose deprivation-induced injury. J. Neurosci. 15, 5840-5850
31. Hoffman, M-C. et al. (1992) The prolonged presence of glia-derived nexin, an endogenous protease inhibitor, in the hippocampus after ischemia-induced delayed neuronal death. Neuroscience 42, 397-408
32. Suzuki, M. et al. (1992) Thrombin activity in cerebrospinal fluid after subarachnoid hemorrhage. Stroke 23, 1181-1182
33. Lee, K.R. et al. (1996) Edema from intracerebral hemorrhage: the role of thrombin. J. Neurosurg. 84, 91-96
34. Majerus, P.W. et al. (1996) Anticoagulant, thrombolytic, and antiplatelet drugs. In Goodman & Gilman's The Pharmacological Basis of Therapeutics, (J.G. Hardman, et al., eds) pp. 1341-1360, McGraw-Hill
35. Colon, G.P. et al. (1996) Thrombin-soaked gelatin sponge and brain edema in rats. J. Neurosurg. 85, 335-339
36. Wang, Y.F. et al. (1998) Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat. Med. 4, 228-231
37. Del Zoppo, G.J. (1998) tPA: a neuron buster too? Nat. Med. 4, 148-150
38. Nagy, Z. et al. (1998) Perturbation of the integrity of the blood-brain barrier by fibrinolytic enzymes. Blood Coag. Fibrinolysis 9, 471-478
39. Gurwitz, D. and Cunningham, D.D. (1988) Thrombin modulates and reverses neuroblastoma neurite outgrowth. Proc. Natl. Acad. Sci. U. S. A. 85, 3440-3444
40. Suidan, H.S. et al. (1992) Thrombin causes neurite retraction in neuronal cells through activation of cell surface receptors. Neuron 8, 363-375
41. Turgeon, V.L. et al. (1998) Thrombin perturbs neurite outgrowth and induces apoptotic cell death in enriched chick spinal motoneuron cultures through caspase activation. J. Neurosci. 18, 6882-6891
42. Nagata, K. et al. (1993) Microglia-derived plasminogen enhances neurite outgrowth from explant cultures of rat brain. Int. J. Dev. Neurosci. 11, 227-237
43. Baranes, D. et al. (1998) Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway. Neuron 21, 813-825
44. Liu, Y. et al. (1994) Proteolytic action of thrombin is required for electrical activity-dependent synapse reduction. Proc. Natl. Acad. Sci. U. S. A. 91, 10300-10304
45. Debeir, T. et al. (1998) Involvement of protease-activated receptor-1 in the in vitro development of mesencephalic dopaminergic neurons. Neuroscience 82, 739-752
46. Cavanaugh, K.P. et al. (1990) Reciprocal modulation of astrocyte stellation by thrombin and protease nexin-1. J. Neurochem. 54, 1735-1743
47. Debeir, T. et al. (1996) Transduction mechanisms involved in thrombin receptor-induced nerve growth factor secretion and cell division in primary cultures of astrocytes. J. Neurochem. 66, 2320-2328
48. Pindon, A. et al. (2000) Thrombomodulin as a new marker of lesion-induced astrogliosis: involvement of thrombin through the G-protein-coupled protease-activated receptor-1. J. Neurosci. 20, 2543-2550
49. Nishino, A. et al. (1993) Thrombin may contribute to the pathophysiology of central nervous injury. J. Neurotrauma 10, 167-179
50. Motohashi, O. et al. (1997) Hirudin suppresses the invasion of inflammatory cells and the appearence of vimentin-positive astrocytes in the rat cerebral ablation model. J. Neurotrauma 14, 747-754
51. Xi, G. et al. (1998) Role of blood clot formation on early edema development after experimental intracerebral hemorrhage. Stroke 29, 2580-2585
52. Figueroa, B.E. et al. (1998) Plasminogen activators potentiate thrombin-induced brain injury. Stroke 29, 1202-1207
53. Vaughan, P.J. et al. (1995) Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J. Neurosci. 15, 5389-5401
54. Striggow, F. et al. (2000) The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc. Natl. Acad. Sci. U. S. A. 97, 2264-2269
55. Turgeon, V.L. et al. (1999) Activation of the protease-activated thrombin receptor (PAR)-1 induces motoneuron degeneration in the developing avian embryo. J. Neuropathol. Exp. Neurol. 58, 499-504
56. Willmore, L.J. (1990) Post-traumatic epilepsy: cellular mechanisms and implications for treatment. Epilepsia 31 (Suppl. 3), S67-S73
57. Lee, S-T. and Lui, T-N. (1992) Early seizures after mild closed head injury. J. Neurosurg. 76, 435-439
58. Annegers, J.F. et al. (1998) A population-based study of seizures after traumatic brain injuries. N. Engl. J. Med. 338, 20-24
59. Berger, A.R. et al. (1988) Early seizures following intracerebral hemorrhage. Neurology 38, 1363-1365
60. Faught, E. et al. (1989) Seizures after primary intracerebral hemorrhage. Neurology 39, 1089-1093
61. Lancman, M.E. et al. (1993) Risk factors for developing seizures after a stroke. Epilepsia 34, 141-143
62. Arboix, A. et al. (1997) Predictive factors of early seizures after acute cerebrovascular disease. Stroke 28, 1590-1594
63. Lee, K.R. et al. (1997) Seizures induced by intracerebral injection of thrombin: a model of intracerebral hemorrhage. J. Neurosurg. 87, 73-78
64. Willmore, L.J. et al. (1978) Chronic focal epileptiform discharge induced by injection of iron into rat and cat cortex. Science 200, 1501-1503
65. Prince, D.A. (1997) Epilepsy and the too-well-connected brain. Nat. Med. 3, 957-958
66. Mizutani, A. et al. (1997) Postsynaptic blockade of inhibitory postsynaptic currents by plasmin in CA1 pyramidal cells of rat hippocampal slices. Brain Res. 761, 93-96
67. Luthi, A. et al. (1997) Endogenous serine protease inhibitor modulates epileptic activity and hippocampal long term potentiation. J. Neurosci. 17, 4688-4699
68. Qian, Z. et al. (1993) Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling, and long term potentiation. Nature 361, 453-457
69. Zhuo, M. et al. (2000) Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation. J. Neurosci. 20, 542-549
70. Tsirka, S.E. (1997) Clinical implications of the involvement of tPA in neuronal cell death. J. Mol. Med. 75, 341-347
71. Tsirka, S.E. et al. (1995) Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 377, 340-344
72. Matsuoka, Y. et al. (1998) Induction of plasminogen in rat hippocampal pyramidal neurons by kainic acid. Neurosci. Lett. 252, 119-122
73. Nagai, N. et al. (1999) Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice. Circulation 99, 2440-2444
74. Tsirka, S.E. et al. (1997) Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin. Proc. Natl. Acad. Sci U. S .A. 94, 9779-9781
75. Kim, Y-H. et al. (1999) Nonproteolytic neuroprotection by human recombinant tissue plasminogen activator. Science 284, 647-650
76. Mun-Bryce, S. and Rosenberg, G.A. (1998) Matrix metalloproteinases in cerebrovascular disease. J. Cereb. Blood Flow Metab. 18, 1163-1172
77. Junge, C. et al. (1999) Plasmin and thrombin regulation of NMDA receptor function. Soc. Neurosci. Abstr. 25, 1979
78. Chen, Z-L. and Strickland, S. (1997) Neuronal death in the hippocampus is promoted by plasmin-catalysed degradation of laminin. Cell 91, 917-925
79. Endo, A. et al. (1999) Proteolysis of neuronal cell adhesion molecule by the tissue plasminogen activator-plasmin system after kainate injection in the mouse hippocampus. Neurosci. Res. 33, 1-8
80. Tsirka, S.E. et al. (1997) An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J. Neurosci. 17, 543-552
81. Chen, Z-L. et al. (1999) Neuronal death and blood-brain barrier breakdown after excitotoxic injury are independent processes. J. Neurosci. 19, 9813-9820
82. Tabrizi, P. et al. (1999) Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model. Aterioscler. Thromb. Vasc. Biol. 19, 2801-2806
83. Wardlaw, J.M. et al. (1997) Systematic review of evidence on thrombolytic therapy for acute stroke. Lancet 350, 607-614
84. Hacke, W. et al. (1995) Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke J. Am. Med. Assoc. 274, 1017-1025
85. del Zoppo, G.J. et al. (1997) Trends and future developments in the pharmacological treatment of acute stroke. Drugs 54, 9-38